ArticleLung cancer (Amsterdam, Netherlands)2021

Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC.

Nanruoyi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.